Danaher Corporation $DHR Stake Lifted by QRG Capital Management Inc.

QRG Capital Management Inc. increased its position in shares of Danaher Corporation (NYSE:DHRFree Report) by 80.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 59,709 shares of the conglomerate’s stock after purchasing an additional 26,630 shares during the period. QRG Capital Management Inc.’s holdings in Danaher were worth $11,321,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the company. JPL Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter worth $25,000. Elevated Capital Advisors LLC bought a new position in Danaher during the fourth quarter valued at about $26,000. WFA of San Diego LLC bought a new position in Danaher during the second quarter valued at about $26,000. Hilton Head Capital Partners LLC acquired a new position in Danaher during the fourth quarter worth about $27,000. Finally, Clal Insurance Enterprises Holdings Ltd grew its holdings in Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 53 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Trading Down 0.0%

NYSE:DHR opened at $197.85 on Friday. The stock has a fifty day simple moving average of $179.01 and a 200 day simple moving average of $200.54. The firm has a market capitalization of $140.03 billion, a price-to-earnings ratio of 38.27, a price-to-earnings-growth ratio of 2.52 and a beta of 0.79. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the previous year, the company earned $1.88 EPS. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. Sell-side analysts forecast that Danaher Corporation will post 8.44 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is 30.95%.

Analyst Ratings Changes

DHR has been the subject of a number of research analyst reports. Royal Bank Of Canada started coverage on shares of Danaher in a report on Thursday, May 14th. They issued an “outperform” rating and a $200.00 price target for the company. Evercore lifted their price objective on shares of Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 21st. Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. Wells Fargo & Company cut their target price on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 22nd. Finally, Guggenheim reduced their target price on shares of Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $233.61.

Check Out Our Latest Research Report on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

See Also

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.